Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This phase 2 trial is aimed to obtain information on the safety and immunogenicity of the Vi-CRM197 in children and infants from various age groups in the Philippines where Typhoid Fever is highly endemic and an efficacious vaccine against this disease is very much needed.
Epistemonikos ID: a82fdf04f08f94cb871103cfcbaefc63834c599d
First added on: May 06, 2024